Ginkgo Bioworks Holdings Inc (DNA) has risen Thursday morning, with the stock gaining 2.88% in pre-market trading to 3.22. DNA’s short-term technical score of 84 indicates that the stock has traded more bullishly over the last month than 84% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, DNA ranks higher than 88% of stocks. Ginkgo Bioworks Holdings Inc has risen 4.68% over the past month, closing at $3.09 on July 14. During this period of time, the stock fell as low as $2.61 and as high as $3.30. DNA has an average analyst recommendation of Strong Buy. The company has an average price target of $8.26.
Ginkgo Bioworks Holdings Inc has a Long-Term Technical rank of 50. This means that trading over the last 200 trading days has placed the company in the middle with 50% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, DNA ranks better than 74% of stocks.
Important Dates for Investors in DNA:
-Ginkgo Bioworks Holdings Inc is set to release earnings on 8/15/2022. Over the last 12 months, the company has reported EPS of $-1.71. -We do not have a set dividend date for Ginkgo Bioworks Holdings Inc at this time. Click Here To Get The Full Report on Ginkgo Bioworks Holdings Inc (DNA)